AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $343.87
- 52-wk high
- $385.75
- High
- $351.96
- 52-wk low
- $223.52
- Low
- $341.68
- Prev close
- $344.25
- Mkt cap
- $24.37B
- P/E
- 44.0x
- Volume
- 541.8K
- Fwd P/E
- 35.3x
- Beta
- 1.14
- Div yield
- 0.25%
- P/S
- 7.3x
- P/B
- 8.1x
- Profit margin
- +17.0%
- Op margin
- +22.5%
- ROE
- +19.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 13.9% above what analysts expected.
Earnings per share
$2.08 expected
Revenue
No comparable estimate
Q3 2026 guidance
$820.0M to $835.0M
No comparable estimate
Reports Oct 22, 2026, in 39 days
EPS expected
$2.16 to $2.22
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $804.3M | $805.0M | $844.9M | $872.3M |
| Cost of what it sold | $510.8M | $501.1M | $548.5M | $543.1M |
| Gross profit | $293.5M | $303.9M | $296.4M | $329.2M |
| What it spent | ||||
| Research and development | $17.1M | $21.8M | $15.8M | $19.7M |
| Sales and admin | $102.7M | $106.5M | $99.5M | $117.6M |
| Other operating costs | — | $18.5M | $4.0M | $12.8M |
| Total operating expenses | $119.8M | $146.8M | $119.3M | $150.1M |
| What was left | ||||
| Operating profit | $173.7M | $156.6M | $177.1M | $179.1M |
| Interest on debt | $100.0K | $5.3M | $1.9M | $2.6M |
| Profit before tax | $174.0M | $165.4M | $180.1M | $180.1M |
| Tax | $34.0M | $33.3M | $44.7M | $32.2M |
| Net profit | $140.0M | $132.1M | $138.8M | $154.0M |
| EBITDA | $217.1M | $209.5M | $218.5M | $179.1M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
Leans bullishSep 11IceCure Secures China NMPA Approval for ProSense Cryoablation System
Leans bullishSep 11West Pharmaceutical Services senior VP favorite sells $2.77m in stock
NeutralSep 11West Pharmaceutical Services at Wells Fargo conference: growth outlook lifts
BullishSep 10Bank of New York Mellon Corp Acquires New Position in X-Energy, Inc. $XE
Leans bearishSep 10The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?
Leans bullishSep 10The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?
Leans bullishSep 9Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
BullishSep 9
Macro
32 macro signals shaping WST right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results